Investor Relations

INVESTORS & MEDIA

INVESTORS
& MEDIA

We are a leading science and technology company based in Tarrytown, New York, that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in four FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.

NASDAQ REGN

$357.20 3.76 (1.04)%

High 360.05 Low 355.00 Volume 326,159 Market Cap 37.21B
02/24/17 12:19 PM ET | Minimum 20 minutes delay.

Stock information provided by eSignal.

Financial information

NEWSROOM

  • Feb 13

    Regeneron Announces Upcoming 2017 Investor Conference Presentations

    Read on
  • Feb 09

    Regeneron Reports Fourth Quarter and Full Year 2016 Financial and Operating Results

    Read on

EVENTS

  • Raymond James 38th Annual Institutional Investors Conference
    Mar 6, 2017 | 1:05 PM ET

Events & Presentations

NASDAQ REGN

$357.20 3.76 (1.04)%

High 360.05 Low 355.00 Volume 326,159 Market Cap 37.21B
02/24/17 12:19 PM ET | Minimum 20 minutes delay.

Stock information provided by eSignal.

Stock information

Financial information